about
The impact of environmental factors in severe psychiatric disorders.Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulationDecreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brainHDAC1 links early life stress to schizophrenia-like phenotypesIncreased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophreniaDifferential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.[Current overview of structural magnetic resonance imaging in schizophrenia][Neurobiology of schizophrenia: new findings from the structure to the molecules].[Neuropsychiatric aspects of Huntington chorea. Presentation of 2 cases and review of the literature][Neuroimaging findings in posttraumatic stress disorder: review of the literature]Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.Sex-dependent behavioral effects and morphological changes in the hippocampus after prenatal invasive interventions in rats: implications for animal models of schizophrenia.Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophreniaSchizophrenia as a disorder of disconnectivitySex-specific proteome differences in the anterior cingulate cortex of schizophrenia.The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression.Hippocampal volume in chronic posttraumatic stress disorder (PTSD): MRI study using two different evaluation methods.Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patientsEffects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial.Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.Internal capsule size associated with outcome in first-episode schizophrenia.Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.Deciphering the human brain proteome: characterization of the anterior temporal lobe and corpus callosum as part of the Chromosome 15-centric Human Proteome Project.BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.microRNA-34c is a novel target to treat dementiasMK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins.pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulationStructural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.
P50
Q21129355-FDFB0AC7-86C7-48F6-85B5-4B984A6B060DQ21260256-C669693E-E06D-4F42-B365-7BC55F19AB6EQ28188520-29BB0F29-6346-4372-9D7B-4E6B834A8304Q30354021-83AC474F-FAB8-4F83-A4CB-DA49A74DFED9Q30459370-2AC93EBD-50D8-4112-ACBD-F52352A2D198Q30478659-A93741CA-DB4A-4A25-8BCF-99DFCC717166Q30558464-AB8BB885-3354-46BC-A511-70413F95CE0EQ30648316-02284864-0103-4540-B035-037F2BD13E62Q30842754-B8075B27-0B9E-4CD7-B4A1-9FDBC62618FBQ30912421-C33B138F-7CFF-4783-9F45-AFB2C10B19CFQ30993993-F86B1193-6AE2-4BF9-B65C-59B00081A474Q31108616-E6CD116E-0B3F-4377-9CBF-E240092E2630Q33449817-67F3C99D-E067-4402-8695-E5C53E45DA83Q33451012-F03E8251-2DF1-4873-88D3-F162775DC850Q33684720-C9090D67-67B2-40E0-A094-AF08BF99EFC5Q33696761-F890E3FE-C13D-4D2B-80B7-01CE9522E4EAQ34002464-342395E3-1D03-4056-A04F-3EC64F94CA2EQ34109438-2E49A2AB-8661-40CB-BB32-5F6E4E55D174Q34197980-FB5BDA41-598B-43A3-866A-3D2151B5F571Q34330678-1DF56079-3CC8-4D86-B5E1-E52F8574F6AFQ34356381-57B03E48-FC2B-4313-9658-6DFA2457D719Q34526354-A1B88F54-1BA7-4AF4-89DD-D76A1C96220BQ34531769-DDD62739-435D-454F-B0B6-ED7B7D7F4093Q34575008-CA8BBC04-87EF-42A1-AF6B-82752DC4291BQ34628396-2B391C33-7876-453A-ADFE-2139D5936780Q34822147-8B7CF8F6-10F7-4759-9436-ACE573D01E3EQ34888915-B5B92EF4-ED2A-4897-9A24-96D2AA4FC193Q34901885-9B50AC24-D5D4-4C24-B33D-8BFCFFD4768DQ34911118-A7F99AB9-96B1-4820-8553-C6A044F77C35Q34928687-F44149CF-7F16-4844-A659-A6BC95C3A9F1Q35052619-CBDC1F97-87F4-4222-9A5B-4724292C2883Q35179012-57303D88-D40D-4884-A654-924C2F7D53F3Q35422390-53092784-60EF-4FD5-92E6-8CFE08BA2863Q35598966-49BC3E40-C6E7-4C1A-BC96-2F823A0FED2AQ35723798-7C8CC517-78CE-4A13-9376-B466D2DD4691Q35739005-076E54D9-5756-4E34-87F9-29F17AA3726DQ35795263-89DAC898-BB86-4950-8B57-CA80905B5625Q35940273-2333387B-FE96-4A94-A3F8-D533952963BEQ36144096-DEB70C00-E922-499D-9B5C-30F7A6339246Q36297838-2D88C5A9-9102-4555-AFA6-9A00D4E7F3EF
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-5426-4023
@en
name
Andrea Schmitt
@ast
Andrea Schmitt
@en
Andrea Schmitt
@es
Andrea Schmitt
@nl
type
label
Andrea Schmitt
@ast
Andrea Schmitt
@en
Andrea Schmitt
@es
Andrea Schmitt
@nl
prefLabel
Andrea Schmitt
@ast
Andrea Schmitt
@en
Andrea Schmitt
@es
Andrea Schmitt
@nl
P108
P1053
V-3003-2018
P106
P21
P2798
P31
P496
0000-0002-5426-4023